Significant Accounting and Reporting Policies (Tables)
12 Months Ended
Dec. 31, 2013
Accounting Policies [Abstract]  
Transactions in foreign currency
All exchange gains and losses from remeasurement of monetary balance sheet items denominated in non-U.S. dollar currencies are reflected as non-operating income (expenses) in the consolidated statements of operations, as they arise.
 
Exchange rate of 1 U.S. $:
 
NIS
 
Euro
 
At December 31, 2013
 
3.471
 
0.726
 
At December 31, 2012
 
3.733
 
0.759
 
Average exchange rate for the year ended December 31, 2013
 
3.611
 
0.753
 
Property and Equipment
    Leasehold improvements are amortized over the shorter of the useful life of the asset or the term of the lease.
 
Annual depreciation rates are as follows: 
 
 
%
 
Office furniture and equipment
 
7-33
 
Computers and related equipment
 
33
 
Leasehold improvements
 
10-33
 
 
Computation of Basic and Diluted Net Losses Per Common Share
The table below presents the computation of basic and diluted net losses per common share:    
 
 
 
Year ended December 31,
 
Cumulative from June 8, 2011
(Inception) through
 
 
 
2013
 
2012
 
December 31, 2013
 
Basic Numerator:
 
 
 
 
 
 
 
 
 
 
Loss from continuing operations attributable to shares of
    common stock
 
$
(41,748)
 
$
(18,409)
 
$
(62,911)
 
Loss from discontinued operations attributable to shares of
    common stock
 
$
(10,685)
 
$
(2,432)
 
$
(13,117)
 
Net loss attributable to shares of common stock
 
$
(52,433)
 
$
(20,841)
 
$
(76,028)
 
Basic Denominator:
 
 
 
 
 
 
 
 
 
 
Weighted average number of shares of common stock outstanding
    during the period
 
 
83,097,667
 
 
38,949,305
 
 
50,004,601
 
Weighted average number of penny stock options
 
 
104,024
 
 
161,871
 
 
100,872
 
Basic common stock share outstanding
 
 
83,201,691
 
 
39,111,176
 
 
50,105,473
 
Basic loss per common stock share from continuing
    operations
 
$
(0.50)
 
$
(0.47)
 
$
(1.26)
 
Basic loss per common stock share from discontinued
    operations
 
$
(0.13)
 
$
(0.06)
 
$
(0.26)
 
Basic net loss per common stock share
 
$
(0.63)
 
$
(0.53)
 
$
(1.52)
 
 
 
 
 
 
 
 
 
 
 
 
Diluted Numerator:
 
 
 
 
 
 
 
 
 
 
Net loss attributable to shares of common stock
 
$
(41,748)
 
$
(18,409)
 
$
(62,911)
 
Increase in net loss attributable to derivative warrants
 
$
(59)
 
$
(4,701)
 
$
(3,336)
 
Diluted net loss from continuing operations attributable to
    shares of common stock
 
$
(41,807)
 
$
(23,110)
 
$
(66,247)
 
Diluted net loss from discontinued operations attributable to
    shares of common stock
 
$
(10,685)
 
$
(2,432)
 
$
(13,117)
 
Diluted net loss attributable to shares of common stock
 
$
(52,492)
 
$
(25,542)
 
$
(79,364)
 
 
 
 
 
 
 
 
 
 
 
 
Diluted Denominator:
 
 
 
 
 
 
 
 
 
 
Basic common stock share outstanding
 
 
83,201,691
 
 
39,111,176
 
 
50,105,473
 
Weighted average number of derivative warrants outstanding
    during the period
 
 
79,182
 
 
2,553,500
 
 
1,513,424
 
Diluted common stock share outstanding
 
 
83,280,873
 
 
41,664,676
 
 
51,618,897
 
Diluted loss per common stock share from continuing
operations
 
$
(0.50)
 
$
(0.55)
 
$
(1.28)
 
Diluted loss per common stock share from discontinued
operations
 
$
(0.13)
 
$
(0.06)
 
$
(0.26)
 
Diluted net loss per common stock share
 
$
(0.63)
 
$
(0.61)
 
$
(1.54)
 
 
 
 
 
 
 
 
 
 
 
 
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially
    dilutive securities, as of December 31 of the applicable period, as they had an anti-dilutive impact:
 
Both vested and unvested options at $0.96-$5.50 exercise price, to
    purchase an equal number of shares of common stock of
    the Company
 
 
10,407,157
 
 
8,942,929
 
 
10,407,157
 
Unvested penny options to purchase an equal number of
    shares of common stock of the Company
 
 
 
 
14,125
 
 
 
Unvested RSUs to issue an equal number of shares of common stock
    of the Company
 
 
2,161,402
 
 
3,125,000
 
 
2,161,402
 
Common stock shares granted, but not yet vested
 
 
30,046
 
 
92,903
 
 
30,046
 
Warrants to purchase an equal number of shares of common stock
    of the Company
 
 
18,261,031
 
 
3,787,628
 
 
15,202,513
 
Total number of potentially dilutive instruments, excluded
    from the calculation of net loss per share:
 
 
30,859,636
 
 
15,962,585
 
 
27,801,118